Ryan Charles S. — SEC Form 4 filings

SEC reporting owner CIK 1624830. 5 Form 4 filings on record with FilingPulse; latest filed 2026-01-23.

Transaction summary — filings shown

Covers all 5 filings on record, filed 2024-02-02 to 2026-01-23. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Quince Therapeutics, Inc. (QNCX)President51 leg · 48,387 sh · $31,4525

Form 4 filings — Ryan Charles S.

FiledFormIssuerReported transactionsSource
2026-01-234Quince Therapeutics, Inc. (QNCX)Grant/award (A): 200,000 (derivative) @ $0EDGAR
2025-06-234Quince Therapeutics, Inc. (QNCX)Grant/award (A): 7,548 @ $1.20 · Grant/award (A): 7,548 (derivative) @ $0.12EDGAR
2025-02-114Quince Therapeutics, Inc. (QNCX)Grant/award (A): 300,000 (derivative) @ $0EDGAR
2024-08-224Quince Therapeutics, Inc. (QNCX)Purchase (P): 48,387 @ $0.65EDGAR
2024-02-024Quince Therapeutics, Inc. (QNCX)Grant/award (A): 145,000 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1624830 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →